Roche announced that it has entered into a strategic alliance with Technoclone. The alliance supports plans Roche announced in October 2011 to develop a new line of analyzers for the central coagulation lab, which will be marketed under Roche's cobas(R) brand. The new line is expected to be introduced in the U.S. and Canada in 2014, subject to regulatory approval and other requirements. As part of the alliance, Roche will also market Technoclone's range of Research Use Only products that address the needs of specialists and researchers in the hemostasis research community.